Skip to content
AIPressRoom

FundingHealthcare & Biotech

DYAD Closes £7.5M to Expand NHS AI

DYAD closed £7.5M Series A led by Sangha Capital to expand its AI-powered clinical coding platform across the NHS and internationally.

Dr Alexander Tayler, CEO of DYAD

The big picture: UK healthcare AI company DYAD has closed a £7.5 million Series A round to accelerate its expansion across the NHS and into new international markets.

Why it matters:

  • Administrative Burden: Healthcare systems face a significant challenge in managing vast amounts of unstructured patient data, leading to substantial administrative costs and inefficiencies.
  • Data Coordination: DYAD’s technology directly addresses the coordination gap between primary and secondary care by transforming complex clinical documents into actionable, structured data.
  • Market Expansion: The investment will enable DYAD to deepen its penetration in the UK’s NHS and extend its AI solutions to secondary care, mental health services, and new markets like the Middle East and the United States.

How it works:

  • GENIE System: DYAD’s proprietary AI system, GENIE, converts unstructured clinical documents into structured data, making it compatible with patient records and enabling agentic systems to act on the information.
  • BetterLetter Platform: In primary care, GENIE powers BetterLetter, an AI-driven clinical coding platform that has processed over five million documents, streamlining the transfer of information between care settings.
  • Human Oversight: Every AI-generated suggestion is reviewed and approved by a practice team member, ensuring accuracy and maintaining a human-in-the-loop approach for critical patient data.

The catch: While DYAD addresses a critical pain point, the healthcare AI market is increasingly competitive, with numerous startups and established tech giants vying for market share. Integrating new AI systems into complex, legacy healthcare IT infrastructures like the NHS can also present significant deployment and adoption challenges, requiring robust change management and interoperability solutions.

Key Facts

  • Company: DYAD
  • Amount: £7.5M
  • Round: Series A
  • Investors: Sangha Capital (lead), Bill Tai, Carbide Ventures
  • Founders: Dr Alexander Tayler, Dr Steven Hamblin
  • Sector: Clinical Coding AI
  • Headquarters: United Kingdom

Funding Weekly

Every AI funding round we reported last week: the totals, the biggest deals and what they add up to. Weekly · Tuesdays.

More in Healthcare & Biotech

All